Navigation Links
Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research
Date:3/16/2009

BETHESDA, Md., March 16 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the publication of six abstracts for poster presentations at the 100th annual meeting of AACR taking place from April 20-24, 2009, in Denver, Colorado.

The following posters will be presented:

  1. Lutterbuese, R. et al. (2009). Highly efficient lysis of KRAS- and BRAF-mutated human colon cancer cells by T cell-engaging BiTE antibodies derived from anti-EGFR antibodies cetuximab and panitumumab. AACR Annual Meeting 2009, abstract no. 3251; to be presented in session 'Immunology 5' on April 21, 2009, 8:00 AM in Hall B-F, poster section 12.
  2. Muenz, M. et al. (2009). Eradication of colon cancer stem cells by EpCAM/CD3-bispecific BiTE antibody MT110. AACR Annual Meeting 2009, abstract no. 3250; to be presented in session 'Immunology 5' on April 21, 2009, 8:00 AM in Hall B-F, poster section 12.
  3. Kischel, R. et al. (2009). Effector memory T cells make a major contribution to redirected target cell lysis by T cell-engaging BiTE antibody MT110. AACR Annual Meeting 2009, abstract no. 3252; to be presented in session 'Immunology 5' on April 21, 2009, 8:00 AM in Hall B-F, poster section 12.
  4. Oberst, M. et al. (2009). In vitro pharmacological comparison of a carcinoembryonic antigen (CEA; CEACAM5; CD66e)/CD3 bispecific cynomolgus-reactive BiTE antibody (CyS111) biosimilar with the clinical candidate MEDI-565 (MT111). AACR Annual Meeting 2009, abstract no. 3247; to be presented in session 'Immunology 5' on April 21, 2009, 8:00 AM in Hall B-F, poster section 12.
  5. Torisu-Itakura, H. et al. (2009). Anti-tumor activity of a T cell-engaging MC
    '/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/--Formanybusinesses,2009hasbeenapainfulyear.Not...ngnetworkofexpertphysiciansspecializingexclusively...wnthenumberof physiciansinitsnetwork sinceNove...dmorephysician-ownedcenters,includingoneinPuertoRi...gicMDhasopened13newbioidenticalhormonespecialtypra...
(Date:11/25/2009)...r.comannouncesthatanewmarketresearchreportisavaila...alysisandForecaststo2013 ,, http://www.report...sis-and-Forecasts-to-2013.html ,, BrazilBioeth...y ,, Thereportprovidesdetailedanalysisandforec...nolmarketinparticular.Italsohelpsinanalyzingandfor...
(Date:11/24/2009)...ES(Nasdaq: IESC ),aleadingnationalproviderofelectr...rcial,industrialandresidentialmarkets,announcedtod...tractfromManhattanTorconJVtoinstalltheelectricalsy...cilityattheU.S.ArmyMedicalResearchInstituteofInfec.... ,, ThenewUSAMRIIDreplacementfacilitywilladdap...
(Date:11/24/2009)...omoreprestigiousuniversitieshavejoinedBioCareerCen...forlifescienceprofessionals. ,, Northwesternand...ng28othermajorlifesciencetrainingInstitutions. ,...post-graduatesinthelifesciences.Whiletherearehundr...Centeristheonlyonethatserveslifesciencepost-gradua...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2
...SBANE, Calif., Jan. 6 InterMune, Inc.,(Nasdaq: ...man, Chief Executive,Officer and President of Inte... Healthcare Conference in San Francisco on January... audio webcast of the presentation, investors and ...r relations page of InterMune,s,corporate website ...
..., Jan. 6 Omeros Corporation today announced that ...5,000 grant against milestones to support the Comp... to evaluate Omeros, recent discovery of a new tar...ted in regions of the brain responsible for Parkin...el target to the treatment of any movement disorde...
...AUGA, ON, Jan. 6 /PRNewswire-FirstCall/ - Vasogen ...pdate on corporate activities. Pursuant to a previ...en reviewing strategic alternatives for the purpos... included screening, reviewing, and short-listing ...Company, a merger or acquisition, and exploring th...
Other Biology Technology:Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 2Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 3Vasogen Provides Corporate Update 2Vasogen Provides Corporate Update 3
(Date:11/24/2009)...ystallised a protein that may help gut bacteria bi...d be used by probiotic producers to identify strai.... , "Probiotics need to interact with cells linin... attach to surfaces in the gut they are more likel...ity," says Dr Nathalie Juge from the Institute of ...
(Date:11/24/2009)...W YORK (November 24, 2009) -- The Wildlife Conserv...ling that the last remaining population of Siberia...the rising tide of poaching and habitat loss. , ...ussian officials of what needs to be done to prote...t. , The report was released by the...
(Date:11/24/2009)...vailable in Spanish . , The presence of inc...flammatory substances in the blood, hinders the lo...esearch project of the University of Navarra condu...he School of Pharmacy. , The project, entitled "...to the control of body weight and inflammation," e...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Enzyme doesnt act alone in atrial fibrillation 8877 1Enzyme doesnt act alone in atrial fibrillation 8877 2The bitter side of sweeteners 8874 1The bitter side of sweeteners 8874 2BenefitMall Hosts New World of Healthcare Forum to Empower Partners to Find Solutions for Volatile Healthcare Industry 49218 1BenefitMall Hosts New World of Healthcare Forum to Empower Partners to Find Solutions for Volatile Healthcare Industry 49218 2BenefitMall Hosts New World of Healthcare Forum to Empower Partners to Find Solutions for Volatile Healthcare Industry 49218 3
...day approved Symlin, an injectable medicine to con... diabetes. Symlin is to be used in addition to ins...te control of their blood sugars on intensive insu...py for the treatment of type 1 diabetes other than...ve several other types of oral therapies available...
... have discovered how fish have evolved over the la...nt water depths. , A research team led by Dr Mich...School of Biological Sciences, has revealed how mo...way of floating at certain water levels using a ga... the mechanism that allows fishes to keep the swim...
...Tunisia, supported by the European Commission, hig...g health in countries bordering the Mediterranean ...ortance of Euro-Mediterranean partnerships in orde...fe sciences ?in particular following the mapping o...prove scientific knowledge and approaches to impro...
Other Biology News:FDA Approves New Drug to Treat Type I and Type II Diabetes 2Scientists discover how fish evolved to float at different sea depths 2Measuring the impact of post-genomics on Mediterranean populations 2
... for use with dishes and cell culture clusters. Li...eated to easily match Cornings product number. If ...e old Sigma-Aldrich number (Z71,334-1) or contact ... 1.9 cm handle L 18 cm Sterilization: sterilized Y...
...ns are cytopathic effect inhibition assays, also k...ion assay measures the antibody's ability to neutr...es include; tissue culture supernatents; serum and... is defined as the quantity of interferon required...
...bine the proven features of the pET, BacVector &re...benefits and versatility of each expression system...een extensively tested for performance with variou... each case, expression was similar to that obtaine...
...a base medium for preparation of minimal and synth...lfate but does not contain amino acids. Both bulk ...Each pouch contains reagents to prepare 500 ml of ... S. cerevisiae media. Store at 15C to 30C. Guarant...
Biology Products: